Medicare Enrolled
Dr. John Tumasz, D.O.
Family Medicine · Philadelphia, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tumasz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tumasz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tumasz
Dr. John Tumasz is a family medicine specialist in Philadelphia, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tumasz performed 1,959 Medicare services across 1,404 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tumasz received a total of $22,564 from 54 pharmaceutical and/or device companies across 1279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tumasz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in PA
$22,564 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,959
Medicare services
Top 8% in PA for family medicine
1,404
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
430 | $63 | $125 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
263 | $96 | $140 |
| Annual depression screening | 170 | $19 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
165 | $134 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
150 | $44 | $85 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
146 | $29 | $30 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
141 | $72 | $75 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
94 | $8 | $10 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
84 | $31 | $45 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
74 | $42 | $60 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
67 | $26 | $50 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
66 | $40 | $55 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
57 | $10 | $65 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
26 | $226 | $350 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
13 | $157 | $200 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $158 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,564
Total received (2018-2024)
Avg $3,223/year across 7 years
Top 1% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,564 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,188
2023
$3,350
2022
$3,338
2021
$3,165
2020
$2,286
2019
$3,057
2018
$3,181
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$833
AstraZeneca Pharmaceuticals LP
$366
Lilly USA, LLC
$355
ABBVIE INC.
$354
Amgen Inc.
$293
Novo Nordisk Inc
$255
PFIZER INC.
$248
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$221
Esperion Therapeutics, Inc.
$216
Bayer Healthcare Pharmaceuticals Inc.
$210
Boehringer Ingelheim Pharmaceuticals, Inc.
$167
Bausch Health US, LLC
$155
Exact Sciences Corporation
$136
Otsuka America Pharmaceutical, Inc.
$104
Astellas Pharma US Inc
$70
IDORSIA PHARMACEUTICALS US INC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$35
Biogen, Inc.
$34
Lundbeck LLC
$30
SANOFI PASTEUR INC.
$27
Almatica Pharma LLC
$22
Vanda Pharmaceuticals Inc.
$16
Top 3 companies account for 37.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,862
AstraZeneca Pharmaceuticals LP
$2,011
Amgen Inc.
$1,523
Lilly USA, LLC
$1,399
PFIZER INC.
$1,245
Novo Nordisk Inc
$1,177
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,124
AbbVie Inc.
$1,045
ABBVIE INC.
$958
Esperion Therapeutics, Inc.
$916
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$747
Takeda Pharmaceuticals U.S.A., Inc.
$711
Novartis Pharmaceuticals Corporation
$631
Kowa Pharmaceuticals America, Inc.
$597
Astellas Pharma US Inc
$580
Janssen Pharmaceuticals, Inc
$508
Allergan, Inc.
$398
Bayer Healthcare Pharmaceuticals Inc.
$395
Merck Sharp & Dohme Corporation
$311
Exact Sciences Corporation
$290
Teva Pharmaceuticals USA, Inc.
$287
Allergan Inc.
$273
Otsuka America Pharmaceutical, Inc.
$229
Endo Pharmaceuticals Inc.
$191
Bausch Health US, LLC
$172
Amarin Pharma Inc.
$165
Almatica Pharma LLC
$162
Merck Sharp & Dohme LLC
$146
SANOFI PASTEUR INC.
$133
AbbVie, Inc.
$122
Xeris Pharmaceuticals, Inc.
$120
Biohaven Pharmaceutical Holding Company Ltd.
$108
Eisai Inc.
$101
Corcept Therapeutics
$101
Dexcom, Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$92
Alexion Pharmaceuticals, Inc.
$85
IDORSIA PHARMACEUTICALS US INC
$84
Abbott Laboratories
$83
Axsome Therapeutics, Inc.
$67
Regeneron Healthcare Solutions, Inc.
$56
Sanofi Pasteur Inc.
$35
Biogen, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$31
Lundbeck LLC
$30
Biohaven Pharmaceuticals, Inc.
$21
Celgene Corporation
$20
Seqirus USA Inc
$18
Vanda Pharmaceuticals Inc.
$16
Greer Laboratories, Inc.
$15
Purdue Pharma L.P.
$14
Philips Electronics North America Corporation
$13
Phadia US Inc.
$13
Dynavax Technologies Corporation
$7
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APLENZIN · AREXVY · AUSTEDO · Aimovig · Auvelity · BASAGLAR · BELSOMRA · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CHANTIX · CREON · CYCLOSET · Cologuard Collection Kit · Creon · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FANAPT · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · GARDASIL 9 · GRALISE · GVOKE PFS · HUMALOG · Heplisav-B · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LOREEV XR · LYRICA · Livalo · MENACTRA · MOUNJARO · MYRBETRIQ · Myrbetriq · NASCOBAL · NEXLETOL · NEXLIZET · NUCALA · NURTEC ODT · ORALAIR · OXYCONTIN · Otezla · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SKYCLARYS · SOLIRIS · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · STRENSIQ · SYMBICORT · Strensiq · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · UBRELVY · Ultomiris · VESICARE · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · WELLBUTRIN · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
2,443
Per 100K population
154.4
County median income
$60,698
Nearest hospital
NAZARETH HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tumasz is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with low-engagement industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tumasz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Tumasz performed 430 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tumasz receive payments from pharmaceutical companies?
Yes. Dr. Tumasz received a total of $22,564 from 54 companies across 1,279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tumasz's costs compare to other family medicine physicians in Philadelphia?
Dr. Tumasz's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tumasz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Philadelphia
Browse family medicine physicians in Philadelphia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology